IL6 and lymphopenia: During hospitalization, 12 severe/critical patients with COVID-19 developed multisystem inflammatory syndrome (MIS), which was characterized by elevated inflammatory markers such as CRP, IL-6, and PCT, and the majority of the cases had lymphopenia.